ReviewScience translational medicine2020
Priorities for developing respiratory syncytial virus vaccines in different target populations.
Simon B Drysdale et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it